Loading...
TELI logo

Telescope Innovations Corp.CNSX:TELI Stock Report

Market Cap CA$39.2m
Share Price
CA$0.48
CA$1.36
64.7% undervalued intrinsic discount
1Y77.8%
7D2.1%
Portfolio Value
​
View

Telescope Innovations Corp.

CNSX:TELI Stock Report

Market Cap: CA$39.2m

Telescope Innovations (TELI) Stock Overview

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. More details

TELI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Risk Analysis

Has less than 1 year of cash runway

Shareholders have been substantially diluted in the past year

Volatile share price over the past 3 months compared to the Canadian market

Does not have a meaningful market cap (CA$39M)


TELI Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives
GANX logo
GANXFeatured

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.
View narrative
Community Contributor
US$7.6FV • 75.1% undervalued intrinsic discount
5022.2%Revenue growth p.a.
3.7k
23
2
54
28d ago

Telescope Innovations Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Telescope Innovations
Historical stock prices
Current Share PriceCA$0.48
52 Week HighCA$0.65
52 Week LowCA$0.24
Beta1.23
1 Month Change23.08%
3 Month Change23.08%
1 Year Change77.78%
3 Year Change242.86%
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Recent updates

Shareholder Returns

TELICA Life SciencesCA Market
7D2.1%1.3%0.3%
1Y77.8%5.0%36.6%

Return vs Industry: TELI exceeded the Canadian Life Sciences industry which returned 5% over the past year.

Return vs Market: TELI exceeded the Canadian Market which returned 36.6% over the past year.

Price Volatility

Is TELI's price volatile compared to industry and market?
TELI volatility
TELI Average Weekly Movement14.6%
Life Sciences Industry Average Movement8.4%
Market Average Movement10.6%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market4.0%

Stable Share Price: TELI's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: TELI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aHenry Dubinatelescopeinnovations.com

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services.

Telescope Innovations Corp. Fundamentals Summary

How do Telescope Innovations's earnings and revenue compare to its market cap?
TELI fundamental statistics
Market capCA$39.19m
Earnings (TTM)-CA$3.19m
Revenue (TTM)CA$7.11m
5.5x
P/S Ratio
-12.2x
P/E Ratio

Is TELI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TELI income statement (TTM)
RevenueCA$7.11m
Cost of RevenueCA$0
Gross ProfitCA$7.11m
Other ExpensesCA$10.30m
Earnings-CA$3.19m

Last Reported Earnings

Feb 28, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.039
Gross Margin100.00%
Net Profit Margin-44.80%
Debt/Equity Ratio10.6%

How did TELI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/01 21:55
End of Day Share Price 2026/05/01 00:00
Earnings2026/02/28
Annual Earnings2025/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Telescope Innovations Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.